Could your gut bacteria predict your cancer treatment success?
NCT ID NCT03586297
Summary
This study aimed to understand if the types of bacteria in a person's gut and tumor are linked to how well they respond to standard chemotherapy for triple-negative breast cancer. Researchers followed 49 newly diagnosed patients, collecting stool, blood, and tumor samples before, during, and after their chemotherapy treatment. The goal was to see if specific bacteria patterns could predict a complete response to the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Georgetown University
Washington D.C., District of Columbia, 20057, United States
-
Hackensack Meridian Health
Hackensack, New Jersey, 07601, United States
-
Yale University - Yale Cancer Center
New Haven, Connecticut, 06520-8327, United States
Conditions
Explore the condition pages connected to this study.